 Amy Keller
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catechin | 4 | 2025 | 22 | 2.990 |
Why?
| | Mitochondria | 10 | 2026 | 984 | 1.390 |
Why?
| | Vascular Diseases | 2 | 2022 | 251 | 1.090 |
Why?
| | Endothelium, Vascular | 5 | 2026 | 965 | 1.080 |
Why?
| | Mitochondria, Muscle | 3 | 2016 | 121 | 0.930 |
Why?
| | Nitric Oxide Synthase Type III | 6 | 2025 | 204 | 0.840 |
Why?
| | Adipose Tissue | 2 | 2025 | 652 | 0.800 |
Why?
| | Rats, Wistar | 6 | 2025 | 451 | 0.800 |
Why?
| | Cardiovascular Diseases | 4 | 2025 | 2168 | 0.790 |
Why?
| | Glucose | 4 | 2022 | 1047 | 0.750 |
Why?
| | Insulins | 1 | 2022 | 38 | 0.700 |
Why?
| | Insulin | 6 | 2025 | 2507 | 0.680 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2016 | 198 | 0.680 |
Why?
| | Glucose Intolerance | 1 | 2022 | 142 | 0.670 |
Why?
| | Rats | 10 | 2025 | 5597 | 0.600 |
Why?
| | Blood Vessels | 2 | 2018 | 171 | 0.590 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2016 | 452 | 0.570 |
Why?
| | Pterins | 1 | 2018 | 7 | 0.570 |
Why?
| | Homocysteine | 1 | 2019 | 151 | 0.560 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 570 | 0.540 |
Why?
| | Momordica charantia | 3 | 2014 | 12 | 0.540 |
Why?
| | Cysteine | 1 | 2019 | 210 | 0.530 |
Why?
| | Vasodilation | 5 | 2025 | 523 | 0.500 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 48 | 0.480 |
Why?
| | Electron Transport Complex IV | 1 | 2016 | 62 | 0.480 |
Why?
| | Menopause | 1 | 2019 | 320 | 0.470 |
Why?
| | Viral Envelope Proteins | 1 | 2016 | 98 | 0.460 |
Why?
| | Oxidative Stress | 3 | 2026 | 1339 | 0.440 |
Why?
| | Adamantane | 1 | 2015 | 17 | 0.440 |
Why?
| | Saponins | 2 | 2011 | 11 | 0.440 |
Why?
| | Dipeptides | 1 | 2015 | 57 | 0.440 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 266 | 0.410 |
Why?
| | Insulin Resistance | 1 | 2022 | 1241 | 0.400 |
Why?
| | Host-Pathogen Interactions | 1 | 2016 | 371 | 0.380 |
Why?
| | Motor Activity | 2 | 2015 | 721 | 0.380 |
Why?
| | Herpesvirus 3, Human | 1 | 2016 | 336 | 0.370 |
Why?
| | Models, Biological | 1 | 2020 | 1821 | 0.370 |
Why?
| | Aorta | 5 | 2018 | 429 | 0.360 |
Why?
| | Animals | 16 | 2025 | 38058 | 0.350 |
Why?
| | Testosterone | 2 | 2026 | 419 | 0.340 |
Why?
| | Cardiorespiratory Fitness | 2 | 2024 | 72 | 0.340 |
Why?
| | Plant Extracts | 2 | 2011 | 187 | 0.330 |
Why?
| | Fibroblasts | 1 | 2016 | 1034 | 0.320 |
Why?
| | Insulin-Secreting Cells | 2 | 2011 | 388 | 0.310 |
Why?
| | Cell Respiration | 2 | 2020 | 107 | 0.300 |
Why?
| | Costus | 1 | 2008 | 1 | 0.290 |
Why?
| | Nitric Oxide | 3 | 2022 | 897 | 0.280 |
Why?
| | Superoxides | 2 | 2020 | 204 | 0.260 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2020 | 108 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2015 | 2583 | 0.260 |
Why?
| | Postmenopause | 2 | 2019 | 391 | 0.250 |
Why?
| | Sirtuins | 1 | 2026 | 50 | 0.230 |
Why?
| | Estradiol | 2 | 2019 | 533 | 0.230 |
Why?
| | Biological Assay | 1 | 2025 | 128 | 0.220 |
Why?
| | Paracrine Communication | 1 | 2025 | 67 | 0.220 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 59 | 0.210 |
Why?
| | Physical Conditioning, Animal | 2 | 2018 | 243 | 0.210 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.190 |
Why?
| | Pancreas | 1 | 2025 | 341 | 0.190 |
Why?
| | Signal Transduction | 3 | 2022 | 5226 | 0.180 |
Why?
| | Triterpenes | 2 | 2014 | 25 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2020 | 40 | 0.180 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.180 |
Why?
| | Nitric Oxide Synthase | 1 | 2022 | 235 | 0.180 |
Why?
| | Temperature | 1 | 2025 | 679 | 0.170 |
Why?
| | Transgender Persons | 1 | 2024 | 191 | 0.170 |
Why?
| | Respiration | 1 | 2022 | 206 | 0.170 |
Why?
| | Housing | 1 | 2022 | 144 | 0.170 |
Why?
| | Blood Glucose | 3 | 2022 | 2327 | 0.170 |
Why?
| | Lipids | 2 | 2022 | 710 | 0.160 |
Why?
| | Antimycin A | 1 | 2020 | 14 | 0.160 |
Why?
| | Glutathione | 1 | 2022 | 375 | 0.160 |
Why?
| | Vasoconstriction | 2 | 2018 | 217 | 0.160 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 42 | 0.160 |
Why?
| | Endothelial Cells | 1 | 2026 | 869 | 0.150 |
Why?
| | Cell Line | 3 | 2016 | 2882 | 0.150 |
Why?
| | Male | 12 | 2026 | 72315 | 0.150 |
Why?
| | Sirtuin 3 | 1 | 2020 | 60 | 0.150 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 621 | 0.150 |
Why?
| | Heart Diseases | 1 | 2022 | 349 | 0.140 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1496 | 0.140 |
Why?
| | Carbohydrates | 1 | 2018 | 66 | 0.140 |
Why?
| | Protein Kinases | 1 | 2020 | 315 | 0.140 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 88 | 0.130 |
Why?
| | Brachial Artery | 1 | 2019 | 206 | 0.130 |
Why?
| | Muscle Proteins | 1 | 2019 | 244 | 0.130 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 361 | 0.130 |
Why?
| | Carotid Arteries | 1 | 2018 | 207 | 0.130 |
Why?
| | Apoptosis | 1 | 2025 | 2430 | 0.130 |
Why?
| | Glycosides | 2 | 2014 | 42 | 0.120 |
Why?
| | Women's Health | 1 | 2019 | 310 | 0.120 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1087 | 0.120 |
Why?
| | Nutritional Status | 1 | 2019 | 354 | 0.120 |
Why?
| | Plants, Medicinal | 2 | 2014 | 23 | 0.120 |
Why?
| | Genes, Reporter | 1 | 2016 | 275 | 0.110 |
Why?
| | Cytoplasm | 1 | 2016 | 269 | 0.110 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 262 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1098 | 0.110 |
Why?
| | Organelle Biogenesis | 1 | 2015 | 15 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 675 | 0.110 |
Why?
| | Aging | 1 | 2026 | 1966 | 0.110 |
Why?
| | Fruit | 2 | 2014 | 152 | 0.110 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 405 | 0.110 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 46 | 0.110 |
Why?
| | Cell Death | 1 | 2016 | 383 | 0.110 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2015 | 146 | 0.100 |
Why?
| | Humans | 12 | 2026 | 144759 | 0.100 |
Why?
| | Hypoglycemic Agents | 2 | 2014 | 1387 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 675 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4557 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2016 | 618 | 0.090 |
Why?
| | Mitochondrial Dynamics | 1 | 2013 | 40 | 0.090 |
Why?
| | Fetus | 1 | 2016 | 803 | 0.090 |
Why?
| | Phytotherapy | 1 | 2011 | 74 | 0.090 |
Why?
| | Seeds | 1 | 2011 | 74 | 0.080 |
Why?
| | Diet | 1 | 2019 | 1273 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 780 | 0.080 |
Why?
| | Obesity | 3 | 2022 | 3077 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2608 | 0.080 |
Why?
| | Software | 1 | 2015 | 690 | 0.080 |
Why?
| | Female | 6 | 2025 | 78271 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2273 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 354 | 0.070 |
Why?
| | Medicine, Traditional | 1 | 2008 | 23 | 0.070 |
Why?
| | Dominican Republic | 1 | 2008 | 26 | 0.070 |
Why?
| | Injections, Intraperitoneal | 1 | 2008 | 116 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 1795 | 0.070 |
Why?
| | Mice | 4 | 2022 | 18339 | 0.070 |
Why?
| | Plant Leaves | 1 | 2008 | 137 | 0.070 |
Why?
| | PPAR gamma | 2 | 2022 | 176 | 0.060 |
Why?
| | Middle Aged | 4 | 2026 | 35875 | 0.060 |
Why?
| | Young Adult | 2 | 2026 | 14105 | 0.060 |
Why?
| | Subcutaneous Fat | 1 | 2025 | 78 | 0.050 |
Why?
| | Weight Gain | 1 | 2008 | 556 | 0.050 |
Why?
| | Hyperglycemia | 1 | 2008 | 375 | 0.050 |
Why?
| | Adult | 3 | 2026 | 40449 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1263 | 0.050 |
Why?
| | Aged | 2 | 2026 | 25913 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 140 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2014 | 145 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4109 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 26 | 0.050 |
Why?
| | Exercise | 1 | 2014 | 2201 | 0.040 |
Why?
| | Carnitine | 1 | 2022 | 90 | 0.040 |
Why?
| | Fetal Heart | 1 | 2022 | 57 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2024 | 724 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2022 | 174 | 0.040 |
Why?
| | Disease Progression | 1 | 2008 | 2847 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11679 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 833 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 102 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2019 | 161 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2008 | 5992 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2013 | 2527 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2947 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2018 | 283 | 0.030 |
Why?
| | Adolescent | 2 | 2026 | 22428 | 0.030 |
Why?
| | Sterols | 1 | 2014 | 20 | 0.030 |
Why?
| | Caco-2 Cells | 1 | 2014 | 79 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2018 | 699 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2026 | 5868 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 416 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2013 | 20 | 0.020 |
Why?
| | Voltage-Dependent Anion Channel 1 | 1 | 2013 | 15 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 49 | 0.020 |
Why?
| | Biological Transport | 1 | 2014 | 417 | 0.020 |
Why?
| | Vascular Stiffness | 1 | 2018 | 486 | 0.020 |
Why?
| | Uncoupling Protein 3 | 1 | 2012 | 9 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2012 | 20 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 594 | 0.020 |
Why?
| | Ion Channels | 1 | 2012 | 129 | 0.020 |
Why?
| | Heterozygote | 1 | 2013 | 315 | 0.020 |
Why?
| | Gene Deletion | 1 | 2013 | 389 | 0.020 |
Why?
| | Oxidative Phosphorylation | 1 | 2012 | 210 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2012 | 190 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 301 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 750 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 286 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7190 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 462 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1490 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7173 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 346 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4271 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 2061 | 0.010 |
Why?
| | Transcription Factors | 1 | 2012 | 1741 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 17066 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|